当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Chest X-Ray Pattern and Lung Severity Score in COVID-19 Patients

Pannucci Elisa

The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of Diabetic Retinopathy (DR) in subjects with type 2 diabetes. Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. In the cross sectional study, a total of 144 subjects with DR and 147 individuals without DR were assessed. DR was assessed by an experienced ophthalmologist. A validated food frequency questionnaire was administered. In the experimental model, a total of 20 mice were included. One drop of caffeine was randomly administered directly onto the superior corneal surface twice daily for two weeks in each eye. Diabetes mellitus is a chronic hyperglycemic condition that can affect the body’s immune response to SARS-CoV-2. This study aimed to determine the relationship between diabetes mellitus and lung severity in COVID-19 patients. The results of the BRIXIA score to assess lung severity found as many as 77 subjects had a score of 11-18 with 14 people with diabetes mellitus, five people with reactive hyperglycemia.